] i ) in MH adult muscle fibers possessing unidentified human MH mutations in swine expressing the Arg614Cys MH mutation (24, 25, 27) and in cultured cells expressing MH mutations (13, 51, 52). The chronically increased resting [Ca 2ϩ ] i in MHS muscle cells has been suggested to be associated with the increased sensitivity of these cells to caffeine and 4-CmC stimulation (26, 28) . Thus these changes in resting [Ca 2ϩ ] i in MHS muscle cells and their possible contribution to the pathophysiology of MH represent another interesting aspect. On the other hand, other studies using the same fluorescent indicators in adult swine (14, 15) and dyspedic myotubes or human embryonic kidney (HEK) cells transfected with RyR1 cDNAs possessing some MH mutations (12, 48) have failed to measure such an elevation. Furthermore, the mechanistic relationship between MH RyR1 mutations and the possible dysfunction of intracellular Ca 2ϩ homeostasis seen in MH-susceptible individuals with these mutations remain to be established.
is a pharmacogenetic disorder of skeletal muscle triggered in susceptible individuals by inhalation anesthetics and depolarizing skeletal muscle relaxants. This syndrome has been linked to a missense mutation in the type 1 ryanodine receptor (RyR1) in more than 50% of cases studied to date. Using double-barreled Ca 2ϩ microelectrodes in myotubes expressing wild-type RyR1 (WTRyR1) or RyR1 with one of four common MH mutations (MHRyR1), we measured resting intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i). Changes in resting [Ca 2ϩ ]i produced by several drugs known to modulate the RyR1 channel complex were investigated. We found that myotubes expressing any of the MHRyR1s had a 2.0-to 3.7-fold higher resting [Ca 2ϩ ]i than those expressing WTRyR1. Exposure of myotubes expressing MHRyR1s to ryanodine (500 M) or (2,6-dichloro-4-aminophenyl)isopropylamine (FLA 365; 20 M) had no effects on their resting [Ca 2ϩ ]i. However, when myotubes were exposed to bastadin 5 alone or to a combination of ryanodine and bastadin 5, the resting [Ca 2ϩ ]i was significantly reduced (P Ͻ 0.01). Interestingly, the percent decrease in resting [Ca 2ϩ ]i in myotubes expressing MHRyR1s was significantly greater than that for WTRyR1. From these data, we propose that the high resting myoplasmic [Ca 2ϩ ]i in MHRyR1 expressing myotubes is due in part to a related structural conformation of MHRyR1s that favors "passive" calcium leak from the sarcoplasmic reticulum.
ryanodine; FLA 365; bastadin 5; resting intracellular calcium concentration; sarcoplasmic reticulum MALIGNANT HYPERTHERMIA (MH) is a potentially fatal pharmacogenetic syndrome caused by exposure to halogenated volatile anesthetics and/or depolarizing muscle relaxants. The pathophysiology of this syndrome is not yet fully understood. However, it is generally accepted that MH susceptibility (MHS) is caused by abnormal intracellular Ca 2ϩ homeostasis in skeletal muscle cells (33) . The ryanodine receptor gene on chromosome 19q13.1 is the primary molecular locus for MHS in humans. More than 60 mutations of type 1 ryanodine receptor (RyR1) located in three hot spots (hot spot I, 35 -615 aa; hot spot II, 2163-2458 aa; and hot spot III, 4643-4898 aa) have been linked to Ͼ50% of all MHS families (36) . Numerous studies have confirmed that MHS muscles exhibit increased sensitivity to direct RyR1 agonists such as caffeine, halothane, and 4-chloro-m-cresol (4-CmC), and it is thought that this increased sensitivity is likely to be the primary underlying mechanism for triggering the clinical MH syndrome (33) .
Intracellular Ca 2ϩ measurements obtained using Ca 2ϩ -selective microelectrodes and fluorescent indicators have demonstrated that there is a significantly elevated resting intracellular Ca 2ϩ concentration ([Ca   2ϩ ] i ) in MH adult muscle fibers possessing unidentified human MH mutations in swine expressing the Arg614Cys MH mutation (24, 25, 27) and in cultured cells expressing MH mutations (13, 51, 52) . The chronically increased resting [Ca 2ϩ ] i in MHS muscle cells has been suggested to be associated with the increased sensitivity of these cells to caffeine and 4-CmC stimulation (26, 28) . Thus these changes in resting [Ca 2ϩ ] i in MHS muscle cells and their possible contribution to the pathophysiology of MH represent another interesting aspect. On the other hand, other studies using the same fluorescent indicators in adult swine (14, 15) and dyspedic myotubes or human embryonic kidney (HEK) cells transfected with RyR1 cDNAs possessing some MH mutations (12, 48) release from the SR that can be rescued by allosteric modulators of the RyR1 complex.
MATERIALS AND METHODS

Construction and expression of MHRyR1 cDNAs.
A detailed explanation of construction and expression of the MHRyR1s used in the current study has been previously described (53) . With the use of a helper virus-free packaging system, all mutated and WTRyR1 cDNAs were packaged into HSV1 virions, which were then used to transduce 1B5 myotubes (49) at a multiplicity of infection (MOI) of 0.5 for 2 h and then cultured for 48 h before measurement of [Ca 2ϩ ]i at room temperature. As described previously (53) , 1B5 cells (RyR1, RyR2, and RyR3 null) were cultured in growth medium (15% FBS in low-glucose DMEM; GIBCO no. 11885-084) at 37°C to passages 5-10 and then plated on Matrigel (BD Bioscience, San Jose, CA)-coated plates (96-well plates; Opticlear Costar 3614). Differentiation was started when cell density reached 20 -30% confluence by changing growth medium to differentiation medium (0.2% horse serum in low-glucose DMEM). Typical multinuclear myotubes as shown in Fig. 1 were obtained by continued incubation of the cells in differentiation medium at 37°C for 5-7 days.
Preparation of bastadin 5. The bromotyrosine derivative bastadin 5 was extracted and purified from the marine sponge Ianthella basta as previously described (30, 40) .
Immunostaining. Immunostaining for RyR1 expression was performed using monoclonal antibody 34C (Airey JA and Sutko JL, ISHB, University of Iowa, Iowa City, IA) that recognizes both RyR1 and RyR3, and Cy3-conjugated goat anti-mouse secondary antibody (Jackson ImmunoResearch, West Grove, PA). To help identify the cells in which resting [Ca 2ϩ ]i was measured, pictures were taken with grid labels attached to the bottom of the plate before each experiment and then matched to pictures taken with the same grid after immunostaining.
Ca 2ϩ -selective microelectrodes. Double-barreled Ca 2ϩ -selective microelectrodes were prepared as described previously (28) . They were backfilled with the neutral carrier ETH 129 (Fluka, Ronkonkoma, NY) and then with pCa 7. Each Ca 2ϩ -selective microelectrode was individually tested as described previously (23) , and only those with a linear relationship between pCa 3 and pCa7 (Nernstian response, 28.5 mV per pCa unit at 24°C) and a response Ͼ16 -20 mV between pCa 7 and pCa 8 were used experimentally. All electrodes were then recalibrated after taking measurements of resting [Ca 2ϩ ], and if the two calibration curves did not agree within 2.5 mV in the relevant range of the calibration curve (pCa 6 -8) , the data from that microelectrode was discarded. The calcium sensitivity of the Ca 2ϩ microelectrodes was not affected by any of the drugs used in the present study, as determined by direct calibration.
Intracellular Ca 2ϩ measurements. Single myotube impalements were observed through an inverted microscope (Zeiss Axiovert 10) fitted with a ϫ10 eyepiece and a ϫ40 dry objective. The potentials from the 3 M KCl barrel (V m) and the Ca 2ϩ barrel (VCae) were recorded via a high-impedance amplifier at Ͼ10 11 M⍀ (model FD-223; WPI, Sarasota, FL). The potential of the voltage microelectrode (V m) was subtracted electronically from the potential of the Ca 2ϩ electrode (VCae) to give the differential signal (VCa) that represents the resting myoplasmic Ca 2ϩ concentration. Vm and VCa potentials were filtered using a low-pass filter (LPF-30; WPI) at 10 -30 kHz, acquired with a frequency of 1,000 Hz with AxoGraph (version 4.8; Axon Instruments, Foster City, CA), and stored for further analysis.
Three criteria were used as key elements to accept or reject individual measurements of resting [Ca 2ϩ ]i: 1) the calibrations before and after the intracellular Ca 2ϩ determination had to agree with one another within 2.5 mV; 2) an instantaneous change in potential (Vm and VCa) had to occur during the cell impalement, followed by a stable recording (Ϯ2-3 mV) for at least 40 s; and 3) the membrane potential had to be more negative than Ϫ60 mV. In experiments where resting [Ca 2ϩ ]i determinations were carried out twice in the same cell, before and after drug treatment, cells were identified with grid labels attached to the bottom of the plate to allow the identification of an individual cell.
Statistics. All values are expressed as means Ϯ SE. Prism software (version 4.0b) was used for statistical analysis (GraphPad Software, San Diego, CA; www.graphpad.com). One-way ANOVA and Tukey's multiple comparison tests were used to compare the resting [Ca 2ϩ ]i values among cells expressing different RyR1 constructs; paired t-tests were used to compare the resting [Ca 2ϩ ]i values in a single cell before and after drug treatment. Expression of MH RyR1s is associated with higher resting [Ca 2ϩ ] i than expression of WT RyR1s. Although our previous studies clearly showed that human and porcine MH muscle fibers had an elevated myoplasmic resting [Ca 2ϩ ] i compared with nonsusceptible individuals, the mechanism for this increase has never been systematically tested in situ in myotubes expressing MH RyR1s. In the present study, WT RyR1 and four MH RyR1s, R164C, R615C, R2163C, and T4825I, were packaged into HSV virions and used to transduce differentiated 1B5 myotubes (35) . Measurements of membrane potential and resting [Ca 2ϩ ] i in MH RyR1-expressing myotubes showed that expression of MH RyR1s and WT RyR1s caused no significant change in resting membrane potential compared with untransduced 1B5 myotubes. However, cells expressing any of the four MH mutations had a significantly (P Ͻ 0.001) increased resting [Ca 2ϩ ] i compared with cells expressing WT RyR1 (Fig. 2) . The degree of elevation of resting [Ca 2ϩ ] i varied significantly among mutations, with expression of T4825I causing the largest increase (418 Ϯ 10.89 nM, n ϭ 23) and R164C producing the smallest increase (242.3 Ϯ 11.45 nM, n ϭ 18) compared with the WT RyR1 (112 Ϯ 1.9 nM, n ϭ 11). The resting [Ca 2ϩ ] i in T4825I-expressing myotubes was also significantly higher (P Ͻ 0.001) than that of all other con-structs tested; R2163C and R615C had similar [Ca 2ϩ ] i values, and in both of these constructs, [Ca 2ϩ ] i was significantly higher (P Ͻ 0.01) than in R164C.
RESULTS
Measurements of resting [Ca
Probing the mechanism of the MH RyR1-induced increase in myoplasmic [Ca 2ϩ ] i : Ryanodine and FLA 365 do not alter resting myoplasmic [Ca 2ϩ ] i . The alkaloid ryanodine is the classic ryanodine receptor channel modulator. At low concentrations, ryanodine can enhance the open probability of the channel, and at high micromolar concentrations (such as the conditions used in this study), it fully blocks channel conductance (8, 10, 41, 55) and prevents Ca 2ϩ release from the sarcoplasmic reticulum (SR) induced by depolarization, Ca 2ϩ , caffeine, and 4-CmC. Using both fluo-4 and microelectrodes, we have found that incubation of intact myotubes expressing WT RyR1 or any of the four MH RyR1s with 500 M ryanodine for 45 min completely abolished caffeine (20 mM)-induced Ca 2ϩ responses, and this caffeine insensitivity is not a result of significant SR store depletion (data not shown). FLA 365 has been shown to directly inhibit SR Ca 2ϩ release by interacting with the RyR1 by a mechanism distinct from other Ca 2ϩ release inhibitors such as ruthenium red or neomycin (9, 30) . Unlike ruthenium red, FLA 365 is membrane permeant, which permits its use to block RyR-mediated responses in intact cells without microinjection, and unlike ruthenium red, its block is reversible.
To (30, 40) . In combination with 500 M ryanodine, bastadin 5 nearly eliminates the Ca 2ϩ leak unmasked by thapsigargin without causing any Ca 2ϩ store depletion, whereas ryanodine alone does not exhibit such an effect (40) (Fig. 4) . To test the hypothesis that the effect of bastadin 5 allosterically changes the conformation of RyR1 from a ryanodine-insensitive "RyR1 leak conformation" into RyR1s in an actively gating conformation that is sensitive to ryanodine block (see DISCUSSION for detailed description of these proposed RyR1 conformations), we then measured myoplasmic resting [Ca 2ϩ ] i in myotubes before and after incubation with 500 M ryanodine for 45 min followed by incubation with 10 M bastadin 5 for 5 min. As shown previously in this study (see Fig. 3 's t-test) . ϩSignificantly different from all other constructs (P Ͻ 0.01, one-way ANOVA with Tukey's t-test). tubes studied (Fig. 5A) . Furthermore, the degree of reduction in resting [Ca 2ϩ ] i induced by the two drugs in combination was greater for all MH RyR1s than for WT RyR1 (P Ͻ 0.05) in both absolute and percent values (Fig. 5B.) . These data are consistent with a mechanism by which bastadin 5 converts RyR1s that are in a ryanodine-insensitive RyR1 leak conformation into the actively gating conformation that is ryanodine sensitive. The ryanodine-sensitive conformation is largely accepted to represent the high-conductance channel that is typically reconstituted in bilayer lipid membranes. Under resting conditions, the population of ryanodine-insensitive MH RyR1s in the RyR1 leak conformation is larger than the population of WT RyR1 in the RyR1 leak conformation. (52) (12, 24, 29, 48, 51) . At present we cannot explain the basis for why different studies on the same expressed mutation yield different results other than to suggest it is due to the difference in experimental methods. It is important to note that there is a broad variation in the reported absolute resting myoplasmic [Ca 2ϩ ] i for WT RyR1-expressing myotubes and fibers between different studies using the same or different fluorescent Ca 2ϩ indicators [ϳ110 nM (48) ; ϳ50 nM (2); and 35-40 nM (13)], and there is an even larger variation in the absolute values from cells studied in the same laboratory using this technique. We propose that whatever is responsible for this broad variation may be the underlying reason for the inconsistency among studies. In general, the absolute resting [Ca 2ϩ ] i in muscle fibers and myotubes measured using fluorescent Ca 2ϩ indicators is always lower than that measured using electrodes. The most probable explanation for this is the result of buffering of intracellular Ca 2ϩ by these fluorescent dyes, all of which are derivatives of the Ca 2ϩ chelator BAPTA, coupled with the uncertainty about the accuracy of their calibration (K d , temperature, viscosity, intracellular pH, ionic strength) (47) .
DISCUSSION
Mutations of RyR1
One alternative suggestion that could be made is that the resting membrane potential of our cells was low, and that the increased Ca 2ϩ was the result of an abnormal response to partial depolarization. Although it is true that the membrane potential observed in this study was less than resting membrane potential recorded in myotubes and adult cells at 37°C (Ϫ80 mV), the value for the resting membrane potential found in all types of myotubes studied are in accordance with the membrane potential of myotubes and adult cells recorded at temperatures ranging between 20 and 25°C by several other groups (3, 16, 22, 32, 44) . Furthermore, previous studies performed at 37°C in intact humans and pigs also had an higher than normal resting [Ca 2ϩ ] i , suggesting that the increased resting [Ca 2ϩ ] i is not simply an artifact caused by partial depolarization.
We cannot explain why some MH RyR1 mutations cause a higher resting [Ca 2ϩ ] i than others, as shown in Fig. 3 . However, the increased resting [Ca 2ϩ ] i that we found in the present study seems supportive of our previous results from [ 3 H] ryanodine binding analysis, which demonstrated similar differences in sensitivity to caffeine activation and to Ca 2ϩ and Mg 2ϩ inhibition common among MH mutations (53) . The high resting [Ca 2ϩ ] i associated with T4825I might suggest that like COOH-terminal mutations of RyR1 associated with central core disease, MH mutations in this region may be more "leaky," as previous studies have suggested (48) , and related to more significant functional changes than the mutations in the other two hot spots.
The opening and closing of the Ca 2ϩ release channels present within the terminal cisternae of SR are basic events in the Ca 2ϩ release process in skeletal muscle. Ryanodine is a neutral plant alkaloid that is frequently used as a specific ligand for characterizing the gating mechanism of ryanodine receptor (31, 42) . It has been shown that at high concentrations (Ͼ200 M), ryanodine irreversibly inhibits the ability of the RyRs to release Ca 2ϩ without changing the passive electrical properties of the bilayer (8, 41) . Likewise, FLA 365 reversibly inhibits the Ca 2ϩ release channel at the SR in both skeletal and cardiac muscle cells (9, 11) . As shown in RESULTS, treatment of myotubes expressing either WT RyR1 or MH RyR1s with ryanodine (500 M) for 45 min or with FLA 365 (20 M) for 5 min did not significantly modify resting [Ca 2ϩ ] i . This suggests that, similar to cells expressing WT RyR1, the mechanism for the increased resting [Ca 2ϩ ] i seen in cells expressing MH RyR1s is not due to an increase in the spontaneous activity of these channels as a result of the missense mutation leading to enhanced efflux of Ca 2ϩ from the SR. In fact, the current results support previous conclusions that RyR1 in its ryanodine-sensitive actively gating conformation does not contribute to the filling state of the SR stores (40) . This is not surprising with regard to the data of Ward et al. (50) , who demonstrated that the frequency of Ca 2ϩ sparks (which represent spontaneous active gating) in intact myotubes expressing WT RyR1 was very low. In addition, RyR1 gating states are in strong negative control by their association with the DHPR, further reducing the possible contribution that actively gating channels would have on resting Ca 2ϩ levels (21, 54). What may be the most exciting result of this study, the effect of exposure to bastadin 5 alone or the simultaneous exposure to ryanodine and bastadin 5 on the resting [Ca 2ϩ ] i in myotubes expressing WT/MH RyR1, appears to shed some light on the possible mechanism(s) for the chronically elevated resting [Ca 2ϩ ] i in MH muscle cells. Bastadin 5 is a natural product isolated from the marine sponge I. basta, which selectively modulates RyR1's conformation through an allosteric mechanism requiring an intact FKBP12/RyR1 complex. In previous studies (30, 40) , our group has shown that RyRs appear to exist in two conformations. The first is an active gating conformation. In the actively gating "channel" conformation, RyR1 has a finite but variable number of rapid transitions from a closed state to one or more high-conductance open states (ϳ25-100 pS for Ca 2ϩ ). The "gating channel" is readily measured in bilayer lipid membrane reconstitutions, where closed and open states and substates can be clearly defined. The probability that the channel is in an open state (P o ) when the Ca 2ϩ concentration is in the physiological range in the myoplasm (60 -300 nM) is very low (Ͻ0.01). When Ca 2ϩ is increased to 100 M, the P o of channels nominally increases to a maximum of ϳ0.4 -0.8, making it possible to see this high-conductance channel rapidly open and close. When a RyR1 in the channel conformation is in the open state, it can bind ryanodine and can be blocked by FLA 365 and ruthenium red. The present studies with bastadin 5 confirm previous results with isolated junctional SR showing that, in addition to the gating channel conformation, which can be completely blocked by all three compounds, an alternate RyR1 leak conformation exists that is insensitive to these drugs and is responsible for setting the filling state of the SR Ca 2ϩ store (30, 40) . The activity of the RyR1 leak conformation is not easily measured in bilayer studies, because based on the rates of efflux that have been previously measured (40) , it is likely to have a much smaller conductance than actively gating channels; and although never directly measured, the RyR1 leak conformation is likely to have a high P o with few transitions to its closed state. Thus it would make only a small contribution to the large background currents typically incorporated in bilayer reconstitutions.
Thus, if incorporated into bilayers, the RyR1 leak conformation would likely make only a small contribution to the relatively large offset current typically incorporated with gating channels. RyR1s in this conformation would be ignored as baseline current. RyR1s in this RyR1 leak conformation cannot and do not bind ryanodine with high affinity. Similarly RyR1 channel blockers such as FLA 365 or ruthenium red cannot and do not act as blockers of the RyR1 leak conformation.
The concept of a channel switching from a leak conformation to one that actively gates is not unique to RyR1. In fact, RyR1 is just one of several in a class of channels that can exist in both conformations. The archetypical channels in this class are the two-pore domain potassium (K2P) channels (for recent reviews, see Refs. 5, 20) . More than sixteen K2P channel genes have been identified in the mammalian genome. All have properties of background or leak K ϩ channels and play a crucial role setting the resting membrane potential and regulating cell excitability. Some of these channels are the targets of G proteins or AKAP150 and can be converted to an actively gating state (17) (18) (19) 43 ). RyR1's smaller "sister" endoplasmic reticulum calcium release channel, the inositol trisphosphate receptor, also has been shown to function as a Ca 2ϩ leak channel when the cytoplasmic control domains are uncoupled from the channel domain of the receptor; however, the mechanism for this uncoupling is as yet unknown (46) . The evidence for the existence of a RyR1 leak conformation from our previous study was that in the presence of bastadin 5, maximum binding for ryanodine binding of SR vesicles could be increased more than twofold while K d remained constant. Likewise, Ca 2ϩ uptake in SR vesicles treated with bastadin 5 increased nearly 2.5-fold in the presence of ryanodine or ryanodine receptor (RR) (20) ] i . The remaining elevation could come from the possibility that we did not use sufficient concentrations of bastadin 5 to convert all of the MH RyRs from their RyR1 leak conformation to an actively gating conformation, since these actions are dose dependent, and/or, more likely, that other mechanisms are also involved.
Other possible mechanisms that could contribute to the remaining intracellular Ca 2ϩ dysfunction observed in muscle cells expressing MH RyR1s could include MH RyR1-related mitochondrial dysfunction (6) that could cause a change in energetics. Such a change, in turn, could lead to an increased resting [Ca 2ϩ ] i by changing SR Ca 2ϩ pump efficiency, causing a possible dysfunction of normal sarcolemmal Ca 2ϩ entry, or by causing a possible dysfunction in Ca 2ϩ extrusion mechanisms. A change in basal energetics in MH-susceptible individuals, demonstrated using 31 P NMR spectroscopy as a increase in the P i /phosphocreatine ratio, was suggested (37-39), but later studies were unable to confirm this abnormality (4, 34) . Furthermore, none of the studies of muscle metabolism that have measured skeletal muscle lactate production using microdialysis have shown any measurable change in baseline values between MH and wild-type humans or pigs (1, 7, 45) . Thus the theory that a defect in metabolism could be the mechanism for the unresolved increase in resting [Ca 2ϩ ] i seems unlikely or at best is highly controversial. However, it is possible that neither of these two techniques are sensitive enough to account for the change in metabolism that would be sufficient to cause the small non-RyR-related increase in resting [Ca 2ϩ ] i that we observed. Further work is required to resolve this issue and answer the question.
Finally, it is important to note that the mechanisms discussed above and the results of this study are only relevant to MH caused by RyR1 mutations and that the mechanisms causing MH resulting from other causes or mutations independent of RyR1 may be entirely different.
